RESUMEN
Governance infrastructures streamline scientific and ethical provenance verification of human pluripotent stem cell (SC) lines. Yet, scientific developments (e.g., SC-derived embryo models, organoids) challenge research governance approaches to stored biospecimens, questioning the validity of informed consent (IC) models. Likewise, e-health platforms are driving major transformations in data processing, prompting a reappraisal of IC. Given these developments, participatory research platforms are identified as effective tools to promote longitudinal engagement, interactive decision-making, and dynamic governance. Learning from European initiatives piloting dynamic IC for biobanking and SC research, this Perspective explores the benefits and challenges of implementing dynamic IC and governance for SC.
Asunto(s)
Humanos , Bases de Datos Factuales , Genética Médica/legislación & jurisprudencia , Genoma Humano , Política de Salud , Salud Pública , Canadá , Conducta Cooperativa , Genética Médica , Genética Médica/métodos , Política de Salud/legislación & jurisprudencia , Derechos Humanos , Difusión de la Información , Cooperación Internacional , Salud Pública/legislación & jurisprudencia , EspañaRESUMEN
No disponible
No disponible